Jim Hightower's Lowdown
Jim Hightower's Radio Lowdown
How Despicable Are Big Pharmacies Insulin Price Gougers?
0:00
Current time: 0:00 / Total time: -2:09
-2:09

How Despicable Are Big Pharmacies Insulin Price Gougers?

Profiteering is always bad, but there are degrees of profiteer. Level 1 includes your everyday price gougers, like banks and airlines. At Level 2, you’ll find the more demonic outfits like loan sharks and for-profit college hucksters. Then top of the heap at Level 3, you’ll find Eli Lilly.

This $288 billion drug making colossus is America’s primary peddler of insulin, the diabetes drug that some seven million Americans must constantly take literally to stay alive. By having both monopoly power over the market and such a huge base of captive customers, Lilly has gleefully jacked up its prices again and again over three decades, with it now costing each sufferer as much as $1,000 a month! Finally, under intense political pressure to stop it’s extreme, life-threatening gouging, the giant recently announced it would soon cut its insulin price by a whopping 70 percent! In full-page ads, Lilly hailed its corporate generosity, magnanimously declaring that “everyone deserves affordable options.”

But – hello! – it has intentionally charged unaffordable rip off prices for 30 years, wallowing in monopoly profits. And – Hello again – if Lilly says it can keep profiting on its insulin product despite slashing the price by 70 percent, that means it has been overcharging patients by 70 percent all this time! Yet, its rich executives want us to thank them? No thank you.

Even with the price cut, they’re still charging $66 for a single vial of insulin. Guess what? It costs Lilly less than $7 to produce that vial, and it could be sold profitably for under $9.

Meanwhile, note that the ballyhooed price cut is voluntary, meaning Lilly can raise the price again at any time. Indeed, David Ricks (who personally pockets $19 million a year from the profiteer) has refused to pledge that he’ll keep the medicine affordable.


Enjoyed this post? Please consider sharing with friends and on social media!

Share

Jim Hightower's Lowdown is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.

Discussion about this episode

You forgot to mention that the patent for insulin was "given" for the price of one dollar by the inventor to the pharmaceutical company.

Expand full comment

Meanwhile, Nova Nordisk's version, the only one that has succeded in keeping my Type1 daughter alive after Eli Lily's nearly killed her, is even MORE expensive than EL's former cost!

Expand full comment

And some people wonder WHY are so MANY insulin takers going to MEXICO to get their "fix" and may end up DEAD, by doing so!!!! One thing is for sure, when David Ricks CROAKS, he WON'T be taking ALL that money with him and it WON'T "buy" him a "nicer" place ..... EITHER!!!

/SHMIRK/

Expand full comment

If they can cut prices by 70 percent, it actually means they have been overcharging by 233 percent.

Expand full comment

You wrote: "And – Hello again – if Lilly says it can keep profiting on its insulin product despite slashing the price by 70 percent, that means it has been overcharging patients by 70 percent all this time!"

I'm no math whiz, but it seems to me that the difference between what they could charge (as low as $9) and what they have been charging (as much as $1000) is about 11,000%!

: o )

Expand full comment